Cargando…

Active surveillance for non-muscle invasive bladder cancer

Most of low grade (LG) bladder tumors will experience disease recurrence and very few of them (<2%) will experience disease progression. Therefore active surveillance (AS) for LG non-muscle invasive bladder cancer (NMIBC) has emerged. The goal of our study was to provide a literature review of AS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marcq, Gautier, Hénon, François, Ouzaid, Idir, Fantoni, Jean Christophe, Hermieu, Jean-François, Xylinas, Evanguelos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414342/ https://www.ncbi.nlm.nih.gov/pubmed/30976569 http://dx.doi.org/10.21037/tau.2018.10.20

Ejemplares similares

Contemporary best practice in the use of neoadjuvant chemotherapy in muscle-invasive bladder cancer
por: Marcq, Gautier, et al.
Publicado: (2019)

Neoadjuvant Immunotherapy for Muscle-Invasive Bladder Cancer
por: Peyrottes, Arthur, et al.
Publicado: (2021)

Contemporary surgical and technical aspects of transurethral resection of bladder tumor
por: Ouzaid, Idir, et al.
Publicado: (2019)

Effect of bladder filling volume on detrusor contractility in men with bladder outlet obstruction
por: Hermieu, Nicolas, et al.
Publicado: (2022)

Lymph Node Dissection During Radical Nephro-Ureterectomy for Upper Tract Urothelial Carcinoma: A Review
por: Peyrottes, Arthur, et al.
Publicado: (2022)

Is it Worth Starting Sexual Rehabilitation Before Radical Prostatectomy? Results From a Systematic Review of the Literature
por: Schoentgen, Nadja, et al.
Publicado: (2021)

The present and future of non-muscle invasive bladder cancer
por: Moschini, Marco, et al.
Publicado: (2019)

Current Advances in Immune Checkpoint Inhibition and Clinical Genomics in Upper Tract Urothelial Carcinoma: State of the Art
por: Califano, Gianluigi, et al.
Publicado: (2022)

Lymphadenectomy for Upper Tract Urothelial Carcinoma: A Systematic Review
por: Duquesne, Igor, et al.
Publicado: (2019)

Prediction tools in non-muscle invasive bladder cancer
por: Zamboni, Stefania, et al.
Publicado: (2019)

Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer
por: Roperch, Jean-Pierre, et al.
Publicado: (2016)

Laparoscopic Partial Nephrectomy: Is It Worth Still Performing the Retroperitoneal Route?
por: Ouzaid, Idir, et al.
Publicado: (2012)

Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer and Its Impact on Surgical Morbidity and Oncological Outcomes: A Real-World Experience
por: Nguyen, Thanh-Tuan, et al.
Publicado: (2018)

Large-scale analysis of cell-cell communication reveals angiogenin-dependent tumor progression in clear cell renal cell carcinoma
por: Massenet-Regad, Lucile, et al.
Publicado: (2023)

The contemporary role and impact of urine-based biomarkers in bladder cancer
por: Duquesne, Igor, et al.
Publicado: (2017)

Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial Group
por: Marcq, Gautier, et al.
Publicado: (2022)

Surveillance and Treatment of Non-Muscle-Invasive Bladder Cancer in the USA
por: Barocas, Daniel A., et al.
Publicado: (2012)

Assessment of the oncological outcomes of three different bacillus Calmette–Guérin strains in patients with high-grade T1 non-muscle-invasive bladder cancer
por: Nowak, Łukasz, et al.
Publicado: (2021)

Postoperative Chemotherapy Bladder Instillation After Radical Nephroureterectomy: Results of a European Survey from the Young Academic Urologist Urothelial Cancer Group
por: Dobé, Tom-Régis, et al.
Publicado: (2020)

Feasibility and Impact of Immunohistochemistry-based Molecular Subtyping for Muscle-invasive Bladder Cancer in Patients Treated with Radiation-based Therapy
por: Hesswani, Charles, et al.
Publicado: (2023)

Consensus Definition and Prediction of Complexity in Transurethral Resection or Bladder Endoscopic Dissection of Bladder Tumours
por: Roumiguié, Mathieu, et al.
Publicado: (2020)

Cost‐effectiveness of surveillance schedules in older adults with non‐muscle‐invasive bladder cancer
por: Heijnsdijk, Eveline A.M., et al.
Publicado: (2018)

The need to improve TURB: a diagnostic and therapeutic fundamental first step in the disease’s management
por: Moschini, Marco, et al.
Publicado: (2019)

Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic Benefit
por: Krajewski, Wojciech, et al.
Publicado: (2020)

Role of Serum Lymphocyte-derived Biomarkers in Nonmetastatic Muscle-invasive Bladder Cancer Patients Treated with Trimodal Therapy
por: Kool, Ronald, et al.
Publicado: (2021)

Impact of Programmed Death-ligand 1 Expression on Oncological Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Radiation-based Therapy
por: Marcq, Gautier, et al.
Publicado: (2022)

An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer
por: Xylinas, Evanguelos, et al.
Publicado: (2016)

Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomes
por: Krajewski, Wojciech, et al.
Publicado: (2020)

Active surveillance for nonmuscle invasive bladder cancer
por: Miyake, Makito, et al.
Publicado: (2016)

An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer
por: Soria, Francesco, et al.
Publicado: (2018)

Identification of Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer by Fourier-Transform Infrared Micro-Imaging
por: Mazza, Camille, et al.
Publicado: (2021)

Systematic review and meta-analysis on bipolar versus monopolar transurethral resection of bladder tumors
por: Krajewski, Wojciech, et al.
Publicado: (2021)

Urinary function and quality of life after radiotherapy for prostate cancer in patients with prior history of surgical treatment for benign prostatic hyperplasia
por: Guilhen, Mélanie, et al.
Publicado: (2018)

Predictors of Outcome of Non–Muscle-Invasive and Muscle-Invasive Bladder Cancer
por: Youssef, Ramy F., et al.
Publicado: (2011)

Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer
por: Zhu, Huier, et al.
Publicado: (2019)

Editorial: Optimal perioperative management of urothelial carcinoma
por: Holzman, Ariane, et al.
Publicado: (2023)

Comparing CxBladder to Urine Cytology as Adjunct to Cystoscopy in Surveillance of Non-muscle Invasive Bladder Cancer—A Pilot Study
por: Chai, C. A., et al.
Publicado: (2021)

Quality of life in patients undergoing surveillance for non-muscle invasive bladder cancer—a systematic review
por: Nayak, Arvind, et al.
Publicado: (2021)

Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition)
por: Jin, Ying-Hui, et al.
Publicado: (2022)

Is Regular Radiographic Upper Urinary Tract Imaging for Surveillance of Non-Muscle Invasive Bladder Cancer Justified?
por: Bieri, Uwe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f3adp85gr3d1k32hut872gmp23